1 Page 1 2 Page 2 3 Preview 4 Complete
Page 1 of 4 (0%)

Please note that completion of this evaluation form is required to receive credits.

Please complete the evaluation by answering all questions.
*
*
This is required to receive your CEUs/Contact Hours. If you do not have an NABP e-Profile ID or are from outside of the United States, please enter N/A.
*
*
Were these learning objectives achieved?
Strongly AgreeAgreeNeutralDisagreeStrongly Disagree
Defend oneself as a compounding pharmacist before the medical community while advocating the advantages of compounded medications.
Assess marketing material and marketing messages against a set of criteria to determine its accuracy, appeal, and overall ability to well promote a compounding practice.
Assess and evaluate expenditures and revenue spreadsheets values over time that is a direct reflection of the costs and earnings of a compounding practice.
Assess acquisition costs in order to establish the selling price of a compounded medication.
Arrange one’s own standard operating procedures incorporating System P as a means of their categorization.
Defend quality, risk, and verification initiatives as a foundation in support of the integrity of the compounding industry.
Create relationships between control, perform, verify, and document against the six categories of System P; personnel, property, procedure, process, preparation, and patient.
Construct quality, risk, and verification protocols for each of the six categories of System P.
Value the requirements under the proposed USP Chapter <800> addressing hazardous drug management and containment; personal protective equipment, hazard communications, medical surveillance, waste management, deactivation and decontamination, handling, storage, preparation, labeling, packaging, shipping, and transportation.
Value the data from recordings from logs and forms related to standard operating procedures and the corrective measures that should be investigated following an assessment of data that falls outside of acceptable norms, parameters, and specifications.
Assess structural, functional, and workflow dynamics-related considerations as it applies to facility design requirements for non-hazardous and hazardous drug compounding.
Construct relationships between routes of delivery, chemical composition, and generalized preparatory procedures for non-sterile dosage forms.
Analyse clinical case scenarios utilizing the concepts; be a star, balancing stability and suitability, and customization with appropriate compromise to aid in the decision-making processes related to medication therapy.
Support the transition from process development, to master formulation record, and to compounding record through the use of a template designed to incorporate the parameters for all three formulation stages.
Manage a clinical case scenario through the use of a flow chart to navigate through your decision-making requirements leading to a compounded medication.
Prepare a broad range of non-sterile dosage forms; hydro-alcoholic gels, rapid dissolve tablets, lollipops, chewable treats for animals, capsules, troches, suppositories, and creams.
*
Were these learning objectives achieved?
Strongly AgreeAgreeNeutralDisagreeStrongly Disagree
Support the marketing initiatives and critical messages put forth by pharmacy owners; specifically their accuracy, appeal, and overall ability to well promote a compounding practice.
Formulate a healthy opinion surrounding the expenditures and revenues generated by a compounding practice, while reading financial spreadsheets that are a direct reflection of its costs and earnings.
Assess acquisition costs associated with technological and chemical purchases in order to appreciate the selling price of a compounded medication.
Compare standard operating procedure requirements against an established system used for their categorization in an effort to ensure the completeness of SOPs in the compounding pharmacy.
Support the quality, risk, and verification initiatives held by a compounding pharmacy as a foundation for excellence in support of the integrity of the compounding industry.
Create relationships between control, perform, verify, and document against the six categories of System P; personnel, property, procedure, process, preparation, and patient.
Support any and all quality, risk, and verification protocols undertaken by a compounding pharmacy for each of the six categories of System P.
Support the initiatives of a compounding pharmacy in relation to the proposed USP Chapter <800> addressing hazardous drug management and containment; personal protective equipment, hazard communications, medical surveillance, waste management, deactivation and decontamination, handling, storage, preparation, labeling, packaging, shipping, and transportation.
Value the data from recordings from logs and forms related to standard operating procedures, a shared responsibility between pharmacist and technician, and the corrective measures that should be investigated following an assessment of data that falls outside of acceptable norms, parameters, and specifications.
Assess structural, functional, and workflow dynamics-related considerations, should the technician which to make recommendations for change, as it applies to facility design requirements for non-hazardous and hazardous drug compounding.
Construct relationships between routes of delivery, chemical composition, and generalized preparatory procedures for non-sterile dosage forms so as to gain an appreciation for the preparatory procedures and excipient requirements of a compounded medication.
Assess clinical case scenarios utilizing the concepts; be a star, balancing stability and suitability, and customization with appropriate compromise so as to gain an appreciation for the complexities surrounding dosage form design and its relationship to medication therapy.
Support the transition from process development, to master formulation record, and to compounding record through the use of a template designed to incorporate the parameters for all three formulation stages.
Value a clinical case scenario flow chart that helps the compounder to navigate through decision-making requirements leading to a compounded medication.
Prepare a broad range of non-sterile dosage forms; hydro-alcoholic gels, rapid dissolve tablets, lollipops, chewable treats for animals, capsules, troches, suppositories, and creams.